Nov 10, 2022 04:05PM
Oct 13, 2022 07:33AM
Oct 13, 2022 07:30AM
Aug 1, 2022 07:31AM
Aug 1, 2022 07:30AM
Jul 25, 2022 04:14PM
Jul 25, 2022 04:05PM Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Jul 18, 2022 07:30AM
May 9, 2022 04:04PM
May 2, 2022 07:30AM
Apr 20, 2022 07:32AM
Apr 20, 2022 07:30AM
Feb 28, 2022 04:27PM
Feb 22, 2022 07:30AM Otonomy Completes Enrollment in Phase 2 Clinical Trial of OTO-313 in Tinnitus
Feb 17, 2022 07:30AM
Jan 6, 2022 07:51AM
Nov 10, 2021 04:18PM
Nov 3, 2021 07:30AM
Oct 12, 2021 07:32AM
Oct 12, 2021 07:30AM
Aug 19, 2021 07:35AM Otonomy (OTIC) Appoints Jill Broadfoot to Board of Directors
Aug 19, 2021 07:30AM
Aug 4, 2021 04:16PM
Jul 28, 2021 07:30AM
May 11, 2021 04:17PM
May 4, 2021 07:30AM
Apr 8, 2021 09:28AM
Apr 7, 2021 05:29PM After-Hours Stock Movers 04/07: (AVCT) (SBBP) (CARG) Higher; (OTIC) (LNDC) (ASO) Lower (more...)
Mar 25, 2021 07:38AM
Mar 25, 2021 07:30AM
Feb 22, 2021 07:03AM
Feb 22, 2021 07:00AM
Feb 11, 2021 04:16PM
Feb 4, 2021 07:30AM
Nov 30, 2020 07:34AM Otonomy (OTIC) Provides Update on OTIVIDEX and OTO-313 Programs
Nov 30, 2020 07:30AM
Nov 4, 2020 04:17PM
Oct 28, 2020 07:30AM
Aug 4, 2020 04:22PM
Jul 28, 2020 04:05PM
Jul 9, 2020 09:31AM
Jun 15, 2020 04:11PM Otonomy (OTIC) Provides Update on Clinical Trials, Development Programs
Jun 15, 2020 04:05PM
May 7, 2020 07:30AM
Apr 9, 2020 07:33AM
Apr 9, 2020 07:30AM
Feb 27, 2020 04:15PM
Feb 20, 2020 07:30AM
Jan 28, 2020 07:32AM Otonomy (OTIC) Highlights Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program
Jan 28, 2020 07:30AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All